中国学者近期发表的论文
1.	LncRNA SNHG16 sponges miR-98-5p to regulate cellular processes in osteosarcoma Author: Shian Liao, Shuxing Xing, Yanhui Ma Journal: CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2019, Vol., , DOI:10.1007/s00280-019-03822-5    DOI
2.	Clinically relevant concentrations of lidocaine inhibit tumor angiogenesis through suppressing VEGF/VEGFR2 signaling Author: Jin Gao, Huimin Hu, Xuesong Wang Journal: CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2019, Vol., , DOI:10.1007/s00280-019-03815-4    DOI
3.	<Emphasis Type="Italic">CDA</Emphasis> and <Emphasis Type="Italic">MTHFR</Emphasis> polymorphisms are associated with clinical outcomes in gastroenteric cancer patients treated with capecitabine-based chemotherapy Author: Duo Liu, Xiang Li, Xuehua Li, Mingyan Zhang, Juan Zhang, Dan Hou, Zhiqiang Tong, Mei Dong Journal: CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2019, Vol., , DOI:10.1007/s00280-019-03809-2    DOI
4.	The PVT1/miR-216b/Beclin-1 regulates cisplatin sensitivity of NSCLC cells via modulating autophagy and apoptosis Author: Liangfeng Chen, Xiaobing Han, Zhongzhou Hu, Liangxin Chen Journal: CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2019, Vol., , DOI:10.1007/s00280-019-03808-3    DOI
5.	Disruption of CTLA-4 expression on peripheral blood CD8 + T cell enhances anti-tumor efficacy in bladder cancer Author: Wei Zhang, Long Shi, Zhilong Zhao, Pingping Du, Xueshuai Ye, Dongbin Li, Zhenhua Cai, Jinsheng Han, Jianhui Cai Journal: CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2019, Vol., , DOI:10.1007/s00280-019-03800-x    DOI
6.	Pharmacokinetics and safety of olaparib tablets as monotherapy and in combination with paclitaxel: results of a Phase I study in Chinese patients with advanced solid tumours Author: Peng Yuan, Jianzhong Shentu, Jianming Xu, Wendy Burke, Kate Hsu, Maria Learoyd, Min Zhu, Binghe Xu Journal: CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2019, Vol., , DOI:10.1007/s00280-019-03799-1    DOI
7.	<Emphasis Type="SmallCaps">d</Emphasis>-dimer increase: an unfavorable factor for patients with primary liver cancer treated with TACE Author: Xujiao Chen, Zhihui Chang, Zhaoyu Liu Journal: CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2019, Vol.83, 797-802, DOI:10.1007/s00280-019-03778-6    DOI
8.	Effect of aprepitant administration on CINV caused by cisplatin multi-day chemotherapy and pharmacokinetics of docetaxel Author: Lin Guo, Hao Peng, Hua-Lin Cai, Dan Tang, Hao Hu, Feng Wang, Jia Liu, Kai-Lin Que, Chen Han, Ying Zhang, Miao Yan, Jin-An Ma Journal: CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2019, Vol.83, 727-734, DOI:10.1007/s00280-019-03777-7    DOI
9.	Analysis of SPARC and TUBB3 as predictors for prognosis in esophageal squamous cell carcinoma receiving nab-paclitaxel plus cisplatin neoadjuvant chemotherapy: a prospective study Author: Lei Gong, Weimin Mao, Qixun Chen, Youhua Jiang, Yun Fan Journal: CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2019, Vol., , DOI:10.1007/s00280-019-03769-7    DOI
10.	The value of serum cystatin C in early evaluation of renal insufficiency in patients undergoing chemotherapy: a systematic review and meta-analysis Author: Liyun He, Jine Li, Jinfeng Zhan, Fengming Yi, Xiude Fan, Yiping Wei, Wenxiong Zhang Journal: CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2019, Vol., , DOI:10.1007/s00280-018-3762-x    DOI

同类著名期刊名称 h-index CiteScore PHARMACOLOGICAL REVIEWS 210 18.73 TRENDS IN PHARMACOLOGICAL SCIENCES 201 9.98 ADVANCED DRUG DELIVERY REVIEWS 278 13.90 DRUG RESISTANCE UPDATES 100 13.15 PHARMACOLOGY & THERAPEUTICS 180 10.16 MEDICINAL RESEARCH REVIEWS 119 8.83 BRITISH JOURNAL OF PHARMACOLOGY 190 6.12 DRUG DISCOVERY TODAY 157 7.08 CLINICAL PHARMACOLOGY & THERAPEUTICS 173 4.47 PHARMACOLOGICAL RESEARCH 118 5.27

中科院JCR同大类学科的热搜期刊 浏览次数 MEDICINE 286005 CANCER RESEARCH 163640 International Journal of Nanomedicine 162050 Molecular Medicine Reports 161916 CANCER LETTERS 157137 JOURNAL OF ETHNOPHARMACOLOGY 138967 BIOMEDICINE & PHARMACOTHERAPY 136940 EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY 133576 Theranostics 132880 International Journal of Environmental Research and Public Health 131239